 | B92 | Name: | (3S)-3-({[(5S,10aS)-2-{(2S)-4-carboxy-2-[(phenylacetyl)amino]butyl}-1,3-dioxo-2,3,5,7,8,9,10,10a-octahydro-1H-[1,2,4]triazolo[1,2-a]cinnolin-5-yl]carbonyl}amino)-4-oxopentanoic acid | Formula: | C29 H35 N5 O9 | SMILES: | CC(=O)[CH](CC(O)=O)NC(=O)[CH]1C=C2CCCC[CH]2N3N1C(=O)N(C[CH](CCC(O)=O)NC(=O)Cc4ccccc4)C3=O | InChi: | InChI=1S/C29H35N5O9/c1-17(35)21(15-26(39)40)31-27(41)23-14-19-9-5-6-10-22(19)33-28(42)32(29(43)34(23)33)16-20(11-12-25(37)38)30-24(36)13-18-7-3-2-4-8-18/h2-4,7-8,14,20-23H,5-6,9-13,15-16H2,1H3,(H,30,36)(H,31,41)(H,37,38)(H,39,40)/t20-,21-,22-,23-/m0/s1 | Definition date: | 2009-11-05 | Last modified: | 2024-09-27 | Identifier: | (3S)-3-[[(5S,10aS)-2-[(2S)-5-hydroxy-5-oxo-2-(2-phenylethanoylamino)pentyl]-1,3-dioxo-5,7,8,9,10,10a-hexahydro-[1,2,4]triazolo[1,2-a]cinnolin-5-yl]carbonylamino]-4-oxo-pentanoic acid |
|
 | B93 | Name: | (3S)-3-({[(5S)-2-{2-[(1H-benzimidazol-5-ylcarbonyl)amino]ethyl}-7-(cyclohexylmethyl)-1,3-dioxo-2,3,5,8-tetrahydro-1H-[1,2,4]triazolo[1,2-a]pyridazin-5-yl]carbonyl}amino)-4-oxopentanoic acid | Formula: | C29 H35 N7 O7 | SMILES: | CC(=O)[CH](CC(O)=O)NC(=O)[CH]1C=C(CC2CCCCC2)CN3N1C(=O)N(CCNC(=O)c4ccc5[nH]cnc5c4)C3=O | InChi: | InChI=1S/C29H35N7O7/c1-17(37)22(14-25(38)39)33-27(41)24-12-19(11-18-5-3-2-4-6-18)15-35-28(42)34(29(43)36(24)35)10-9-30-26(40)20-7-8-21-23(13-20)32-16-31-21/h7-8,12-13,16,18,22,24H,2-6,9-11,14-15H2,1H3,(H,30,40)(H,31,32)(H,33,41)(H,38,39)/t22-,24-/m0/s1 | Definition date: | 2009-11-05 | Last modified: | 2024-09-27 | Identifier: | (3S)-3-[[(8S)-2-[2-(1H-benzimidazol-5-ylcarbonylamino)ethyl]-6-(cyclohexylmethyl)-1,3-dioxo-5,8-dihydro-[1,2,4]triazolo[1,2-a]pyridazin-8-yl]carbonylamino]-4-oxo-pentanoic acid |
|
 | B94 | Name: | (3S)-3-({[(5S,8R)-2-(3-carboxypropyl)-8-(2-{[(4-chlorophenyl)acetyl]amino}ethyl)-1,3-dioxo-2,3,5,8-tetrahydro-1H-[1,2,4]triazolo[1,2-a]pyridazin-5-yl]carbonyl}amino)-4-oxopentanoic acid | Formula: | C26 H30 Cl N5 O9 | SMILES: | CC(=O)[CH](CC(O)=O)NC(=O)[CH]1C=C[CH](CCNC(=O)Cc2ccc(Cl)cc2)N3N1C(=O)N(CCCC(O)=O)C3=O | InChi: | InChI=1S/C26H30ClN5O9/c1-15(33)19(14-23(37)38)29-24(39)20-9-8-18(10-11-28-21(34)13-16-4-6-17(27)7-5-16)31-25(40)30(26(41)32(20)31)12-2-3-22(35)36/h4-9,18-20H,2-3,10-14H2,1H3,(H,28,34)(H,29,39)(H,35,36)(H,37,38)/t18-,19-,20-/m0/s1 | Definition date: | 2009-11-05 | Last modified: | 2024-09-27 | Identifier: | (3S)-3-[[(5R,8S)-5-[2-[2-(4-chlorophenyl)ethanoylamino]ethyl]-2-(4-hydroxy-4-oxo-butyl)-1,3-dioxo-5,8-dihydro-[1,2,4]triazolo[1,2-a]pyridazin-8-yl]carbonylamino]-4-oxo-pentanoic acid |
|
 | B9D | Name: | 5-fluoro-alpha-L-idopyranose | Formula: | C6 H11 F O6 | SMILES: | FC1(OC(O)C(O)C(O)C1O)CO | InChi: | InChI=1S/C6H11FO6/c7-6(1-8)4(11)2(9)3(10)5(12)13-6/h2-5,8-12H,1H2/t2-,3-,4+,5-,6+/m1/s1 | Synonyms: | (2R,3R,4R,5S,6R)-6-fluoranyl-6-(hydroxymethyl)oxane-2,3,4,5-tetrol | Definition date: | 2009-08-18 | Last modified: | 2024-09-27 | Identifier: | (2R,3R,4R,5S,6R)-6-fluoro-6-(hydroxymethyl)tetrahydro-2H-pyran-2,3,4,5-tetrol (non-preferred name) |
|
 | BA0 | Name: | (7S)-2-(4-phenoxyphenyl)-7-(1-propanoylpiperidin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide | Formula: | C27 H31 N5 O3 | SMILES: | C1CN(C(CC)=O)CCC1C3CCNc2c(C(N)=O)c(nn23)c4ccc(cc4)Oc5ccccc5 | InChi: | InChI=1S/C27H31N5O3/c1-2-23(33)31-16-13-18(14-17-31)22-12-15-29-27-24(26(28)34)25(30-32(22)27)19-8-10-21(11-9-19)35-20-6-4-3-5-7-20/h3-11,18,22,29H,2,12-17H2,1H3,(H2,28,34)/t22-/m0/s1 | Synonyms: | Zanubrutinib | Definition date: | 2019-01-30 | Last modified: | 2024-09-27 | Release date: | 2019-10-23 | Identifier: | (7S)-2-(4-phenoxyphenyl)-7-(1-propanoylpiperidin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide |
|
 | BAA | Name: | (TERT-BUTYLOXYCARBONYL)-ALANYL-ALANYL-AMINE | Formula: | C11 H21 N3 O4 | SMILES: | O=C(OC(C)(C)C)NC(C(=O)NC(C(=O)N)C)C | InChi: | InChI=1S/C11H21N3O4/c1-6(8(12)15)13-9(16)7(2)14-10(17)18-11(3,4)5/h6-7H,1-5H3,(H2,12,15)(H,13,16)(H,14,17)/t6-,7-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | N-(tert-butoxycarbonyl)-L-alanyl-L-alaninamide |
|
 | BAF | Name: | (TERT-BUTYLOXYCARBONYL)-ALANYL-AMINO ETHYL-FORMAMIDE | Formula: | C11 H21 N3 O4 | SMILES: | O=C(OC(C)(C)C)NC(C(=O)NC(NC=O)C)C | InChi: | InChI=1S/C11H21N3O4/c1-7(9(16)14-8(2)12-6-15)13-10(17)18-11(3,4)5/h6-8H,1-5H3,(H,12,15)(H,13,17)(H,14,16)/t7-,8-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | N~2~-(tert-butoxycarbonyl)-N-[(1S)-1-(formylamino)ethyl]-L-alaninamide |
|
 | BAL | Name: | BETA-ALANINE | Formula: | C3 H7 N O2 | SMILES: | O=C(O)CCN | InChi: | InChI=1S/C3H7NO2/c4-2-1-3(5)6/h1-2,4H2,(H,5,6) | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | beta-alanine |
|
 | BB6 | Name: | (2Z)-2-amino-3-sulfanylbut-2-enoic acid | Formula: | C4 H7 N O2 S | SMILES: | O=C(O)/C(N)=C(/S)C | InChi: | InChI=1S/C4H7NO2S/c1-2(8)3(5)4(6)7/h8H,5H2,1H3,(H,6,7)/b3-2- | Definition date: | 2009-01-15 | Last modified: | 2024-09-27 | Identifier: | (2Z)-2-amino-3-sulfanylbut-2-enoic acid |
|
 | BB7 | Name: | (2Z)-2-amino-4-methoxy-3-sulfanylbut-2-enoic acid | Formula: | C5 H9 N O3 S | SMILES: | O=C(O)/C(N)=C(/S)COC | InChi: | InChI=1S/C5H9NO3S/c1-9-2-3(10)4(6)5(7)8/h10H,2,6H2,1H3,(H,7,8)/b4-3- | Definition date: | 2009-01-15 | Last modified: | 2024-09-27 | Identifier: | (2Z)-2-amino-4-methoxy-3-sulfanylbut-2-enoic acid |
|
 | BB8 | Name: | (2S,3S)-BETA-HYDROXY-PHENYLALANINE | Formula: | C9 H11 N O3 | SMILES: | O=C(O)C(N)C(O)c1ccccc1 | InChi: | InChI=1S/C9H11NO3/c10-7(9(12)13)8(11)6-4-2-1-3-5-6/h1-5,7-8,11H,10H2,(H,12,13)/t7-,8-/m0/s1 | Synonyms: | BETA-HYDROXY-PHENYLALANINE | Definition date: | 2009-01-15 | Last modified: | 2024-09-27 | Identifier: | (betaS)-beta-hydroxy-L-phenylalanine |
|
 | BB9 | Name: | (2Z)-2-amino-3-sulfanylprop-2-enoic acid | Formula: | C3 H5 N O2 S | SMILES: | O=C(O)/C(N)=C/S | InChi: | InChI=1S/C3H5NO2S/c4-2(1-7)3(5)6/h1,7H,4H2,(H,5,6)/b2-1- | Definition date: | 2009-01-15 | Last modified: | 2024-09-27 | Identifier: | (2Z)-2-amino-3-sulfanylprop-2-enoic acid |
|
 | BBC | Name: | 3-[(4-AMINOBUTYL)SULFINYL]-2-IMINOPROPAN-1-OL | Formula: | C7 H16 N2 O2 S | SMILES: | O=S(CC(=[N@H])CO)CCCCN | InChi: | InChI=1S/C7H16N2O2S/c8-3-1-2-4-12(11)6-7(9)5-10/h9-10H,1-6,8H2/b9-7+/t12-/m0/s1 | Definition date: | 2005-05-18 | Last modified: | 2024-09-27 | Identifier: | (2E)-3-[(S)-(4-aminobutyl)sulfinyl]-2-iminopropan-1-ol |
|
 | BBL | Name: | N-[(BENZYLOXY)CARBONYL]-L-ALANINE | Formula: | C11 H13 N O4 | SMILES: | O=C(O)C(NC(=O)OCc1ccccc1)C | InChi: | InChI=1S/C11H13NO4/c1-8(10(13)14)12-11(15)16-7-9-5-3-2-4-6-9/h2-6,8H,7H2,1H3,(H,12,15)(H,13,14)/t8-/m0/s1 | Synonyms: | N-BENZYLOXYCARBONYL-L-SERINE-BETALACTONE | Definition date: | 2005-07-07 | Last modified: | 2024-09-27 | Identifier: | N-[(benzyloxy)carbonyl]-L-alanine |
|
 | BBR | Name: | (3-bromo-2-oxo-propoxy)phosphonic acid | Formula: | C3 H6 Br O5 P | SMILES: | O=P(O)(O)OCC(=O)CBr | InChi: | InChI=1S/C3H6BrO5P/c4-1-3(5)2-9-10(6,7)8/h1-2H2,(H2,6,7,8) | Definition date: | 2007-10-25 | Last modified: | 2024-09-27 | Identifier: | 3-bromo-2-oxopropyl dihydrogen phosphate |
|
 | BBS | Name: | 4-TERT-BUTYLBENZENESULFONIC ACID | Formula: | C10 H14 O3 S | SMILES: | O=S(=O)(O)c1ccc(cc1)C(C)(C)C | InChi: | InChI=1S/C10H14O3S/c1-10(2,3)8-4-6-9(7-5-8)14(11,12)13/h4-7H,1-3H3,(H,11,12,13) | Definition date: | 2000-03-31 | Last modified: | 2024-09-27 | Identifier: | 4-tert-butylbenzenesulfonic acid |
|
 | BCQ | Name: | N-[(1R)-1-[({[(5S)-3,5-DIMETHYL-2,5-DIHYDROISOXAZOL-4-YL]METHYL}SULFONYL)METHYL]-2-OXO-2-({(1S)-3-PHENYL-1-[2-(PHENYLSULFONYL)ETHYL]PROPYL}AMINO)ETHYL]MORPHOLINE-4-CARBOXAMIDE | Formula: | C31 H42 N4 O8 S2 | SMILES: | O=S(=O)(CC1=C(NOC1C)C)CC(C(=O)NC(CCS(=O)(=O)c2ccccc2)CCc3ccccc3)NC(=O)N4CCOCC4 | InChi: | InChI=1S/C31H42N4O8S2/c1-23-28(24(2)43-34-23)21-44(38,39)22-29(33-31(37)35-16-18-42-19-17-35)30(36)32-26(14-13-25-9-5-3-6-10-25)15-20-45(40,41)27-11-7-4-8-12-27/h3-12,24,26,29,34H,13-22H2,1-2H3,(H,32,36)(H,33,37)/t24-,26-,29-/m0/s1 | Definition date: | 2006-02-08 | Last modified: | 2024-09-27 | Identifier: | N-[(1R)-1-[({[(5S)-3,5-dimethyl-2,5-dihydroisoxazol-4-yl]methyl}sulfonyl)methyl]-2-oxo-2-({(1S)-3-phenyl-1-[2-(phenylsulfonyl)ethyl]propyl}amino)ethyl]morpholine-4-carboxamide |
|
 | BCS | Name: | BENZYLCYSTEINE | Formula: | C10 H13 N O2 S | SMILES: | O=C(O)C(N)CSCc1ccccc1 | InChi: | InChI=1S/C10H13NO2S/c11-9(10(12)13)7-14-6-8-4-2-1-3-5-8/h1-5,9H,6-7,11H2,(H,12,13)/t9-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | S-benzyl-L-cysteine |
|
 | BCT | Name: | BICARBONATE ION | Formula: | C H O3 | SMILES: | [O-]C(=O)O | InChi: | InChI=1S/CH2O3/c2-1(3)4/h(H2,2,3,4)/p-1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | hydrogen carbonate |
|
 | BCX | Name: | (3R)-3-amino-4-sulfanylbutanoic acid | Formula: | C4 H9 N O2 S | SMILES: | O=C(O)CC(N)CS | InChi: | InChI=1S/C4H9NO2S/c5-3(2-8)1-4(6)7/h3,8H,1-2,5H2,(H,6,7)/t3-/m1/s1 | Definition date: | 2001-06-05 | Last modified: | 2024-09-27 | Identifier: | (3R)-3-amino-4-sulfanylbutanoic acid |
|
 | BD1 | Name: | 3A,4,7,7A-TETRAHYDRO-BENZO [1,3] DIOXOL-2-ONE | Formula: | C7 H10 O3 | SMILES: | O1C2CC=CCC2OC1O | InChi: | InChI=1S/C7H10O3/c8-7-9-5-3-1-2-4-6(5)10-7/h1-2,5-8H,3-4H2/t5-,6+,7+ | Definition date: | 2003-03-14 | Last modified: | 2024-09-27 | Identifier: | (2r,3aR,7aS)-3a,4,7,7a-tetrahydro-1,3-benzodioxol-2-ol |
|
 | BD3 | Name: | Nalpha-[(3-tert-butyl-1-methyl-1H-pyrazol-5-yl)carbonyl]-N-[(2E)-2-iminoethyl]-3-{5-[(Z)-iminomethyl]-1,3,4-oxadiazol-2-yl}-L-phenylalaninamide | Formula: | C23 H28 N8 O3 | SMILES: | O=C(NCC=[N@H])C(NC(=O)c1cc(nn1C)C(C)(C)C)Cc3cc(c2nnc(o2)C=[N@H])ccc3 | InChi: | InChI=1S/C23H28N8O3/c1-23(2,3)18-12-17(31(4)30-18)21(33)27-16(20(32)26-9-8-24)11-14-6-5-7-15(10-14)22-29-28-19(13-25)34-22/h5-8,10,12-13,16,24-25H,9,11H2,1-4H3,(H,26,32)(H,27,33)/b24-8+,25-13-/t16-/m0/s1 | Definition date: | 2009-06-19 | Last modified: | 2024-09-27 | Identifier: | Nalpha-[(3-tert-butyl-1-methyl-1H-pyrazol-5-yl)carbonyl]-N-[(2E)-2-iminoethyl]-3-{5-[(Z)-iminomethyl]-1,3,4-oxadiazol-2-yl}-L-phenylalaninamide |
|
 | BDB | Name: | 4,4'-BIPHENYLDIBORONIC ACID | Formula: | C12 H12 B2 O4 | SMILES: | OB(O)c1ccc(cc1)c2ccc(cc2)B(O)O | InChi: | InChI=1S/C12H12B2O4/c15-13(16)11-5-1-9(2-6-11)10-3-7-12(8-4-10)14(17)18/h1-8,15-18H | Definition date: | 2001-11-20 | Last modified: | 2024-09-27 | Identifier: | biphenyl-4,4'-diyldiboronic acid |
|
 | BDF | Name: | beta-D-fructopyranose | Formula: | C6 H12 O6 | SMILES: | OC1C(O)(OCC(O)C1O)CO | InChi: | InChI=1S/C6H12O6/c7-2-6(11)5(10)4(9)3(8)1-12-6/h3-5,7-11H,1-2H2/t3-,4-,5+,6-/m1/s1 | Synonyms: | beta-D-fructose | Definition date: | 2002-11-01 | Last modified: | 2024-09-27 | Identifier: | beta-D-fructopyranose |
|
 | BDK | Name: | 2-[5-AMINO-6-OXO-2-(2-THIENYL)-1,6-DIHYDROPYRIMIDIN-1-YL)-N-[3,3-DIFLUORO -1-ISOPROPYL-2-OXO-3-(N-(2-MORPHOLINO ETHYL)CARBAMOYL]PROPYL]ACETAMIDE | Formula: | C23 H30 F2 N6 O5 S | SMILES: | O=C(NCCN1CCOCC1)C(F)(F)C(=O)C(NC(=O)CN2C(=NC=C(N)C2=O)c3sccc3)C(C)C | InChi: | InChI=1S/C23H30F2N6O5S/c1-14(2)18(19(33)23(24,25)22(35)27-5-6-30-7-9-36-10-8-30)29-17(32)13-31-20(16-4-3-11-37-16)28-12-15(26)21(31)34/h3-4,11-12,14,18H,5-10,13,26H2,1-2H3,(H,27,35)(H,29,32)/t18-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | (4S)-4-{[(5-amino-6-oxo-2-thiophen-2-ylpyrimidin-1(6H)-yl)acetyl]amino}-2,2-difluoro-5-methyl-N-(2-morpholin-4-ylethyl)-3-oxohexanamide |
|